X-Ray Technology to Irradiate Blood and Blood Products

["Sandy Perle" <sandyfl@earthlink.net>]

I expect that this will raise all kinds of red flags, as did food 
irradiation. If the public is terrified of putting food in their mouths, 
that had bee "IRRADIATED" ... wait to they find that the blood that 
will be transfused into their bodies, will be "IRRADIATED"!

Monday March 15, 3:40 pm Eastern Time

Company Press Release

Florida Based Company Announces New Applications for X-Ray 
Technology to Irradiate Blood and Blood Products  

CORAL SPRINGS, Fla.--(BUSINESS WIRE)--March 15, 1999--Rad 
Source Technologies, Inc. (OTC BB:IRAD - news) of Coral Springs, 
Fla. has made a technological breakthrough in the design of a 
proprietary system that irradiates blood and blood products prior to 
transfusion in order to prevent graft versus host disease.  

The RS 3000 Blood Irradiator is a completely self contained X-ray 
irradiation source that provides an alternative to radioactive 
(gamma) irradiation sources. The RS 3000 Blood Irradiator has 
been approved for marketing by the Food and Drug Administration 
(FDA) for the irradiation of blood and blood products. The response 
to the RS 3000 Blood Irradiator has been tremendous with initial 
orders placed for eight units stated Randol Kirk, President and 
CEO. The first unit is scheduled to be delivered within the first 
quarter of 1999 to the South Florida Blood Bank, West Palm 
Beach, Florida. I believe, the RS 3000 Blood Irradiator will 
revolutionize the industry as the first blood irradiator utilizing a non-
radioactive source, we are eagerly awaiting it's arrival. stated John 
Flynn, President and CEO of the South Florida Blood Banks.  

Rad Source Technologies, Inc. is committed to replacing regulated, 
nuclear irradiation devices with X-ray technology for application in 
selected medical and industrial markets. Since its inception, Rad 
Source Technologies has developed, unique, patented technology 
to be sequentially incorporated into three specific product lines, all 
immediately applicable to resolving highly publicized, public health 
and consumer issues, according to Randol E. Kirk, President and 
CEO. Unlike commonly used medical and dental X-ray imaging 
equipment, which must be designed to minimize and focus 
radiation dosage, the new products are designed to provide intense 
long wave X-ray bombardment on demand, but without the inherent 
risks associated with radioactive radiation. ``Our technology has 
greatly reduced the risk and problems associated with 
radioactivity,'' Kirk explained.  

Rad Source Technologies recently completed an equity private 
placement through its investment bankers, Capital International 
Securities Group of Miami, Florida. The equity private placement 
was raised in order to meet anticipated product demand of the 
company's RS 2000 Lab Irradiators and RS 3000 Blood Irradiators. 
The company began trading it's common stock in the public 
markets on 3/13/99 on the OTC BB under the symbol IRAD. Rad 
Source Technologies, Inc. joins MDS Nordion TSE: (MHG.A), 
Sterigenics International Nasdaq: (STER) and Steris Corporation 
NYSE: (STE) in the emerging irradiation industry. For more  
information, visit the Company's web site at radsource.com. 

Sandy Perle
E-Mail: sandyfl@earthlink.net 
Personal Website: http://www.geocities.com/capecanaveral/1205

"The object of opening the mind, as of opening 
the mouth, is to close it again on something solid"
              - G. K. Chesterton -
************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html